[7] Gunawan S., Ayaz M., De Moliner F., Frett B., Kaiser C., Patrick N., Xu Z., Hulme C.,
Synthesis of Tetrazolo-Fused Benzodiazepines and Benzodiazepinones by a Two-Step Protocol Using an Ugi-Azide Reaction for Initial Diversity Generation,
Tetrahedron,
68: 5606-5611 (2012).
[14] Brik A., Muldoon J., Lin Y.C., Elder J.H., Goodsell D.S., Olson A.J., Fokin V.V., Sharpless K.B., Wong C.H.,
Rapid Diversity-Oriented Synthesis in Microtiter Plates for in Situ Screening of HIV Protease Inhibitors,
Chem. Bio. Chem.,
4: 1246-1248 (2003).
[15] Soltis M.J., Yeh H.J., Cole K.A., Whittaker N., Wersto R.P., Kohn E.C.,
Identification and Characterization of Human Metabolites of CAI [5-Amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide,
Drug. Metab. Dispos.,
24: 799-806 (1996).
[16] Alvarez R., Velazquez S., San-Felix A., Aquaro S., De Clercq E., Perno C.F.N., Karlsson A., Balzarini J., Camarasa M.J.,
1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity,
J. Med. Chem.,
37: 4185-4194 (1994).
[23] Rouhi A.M., Traditional Methods Thrive Because Numerous Hurdles, Including Tough Luck, Slow Down the Commercialization of Catalytic Processes, Chem. Eng. News, 82: 47-62 (2004).
[26] Shaabani A., Maleki A., Mofakham H., Moghimi-Rad J.,
A Novel One-Pot Pseudo-Five-Component Synthesis of 4,5,6,7-Tetrahydro-1H-1,4-diazepine-5-carboxamide Derivatives,
J. Org.
Chem.,
73: 3925-3927 (2008).